Document is current
Any future updates will be listed below
-
Authors
Cathcart-Rake, Elizabeth
Novotny, Paul
Leon-Ferre, Roberto
Le-Rademacher, Jennifer
Storrick, Elizabeth M.
Adjei, Araba A.
Terstriep, Shelby
Glaser, Rebecca
Giuliano, Armando
Mitchell, William R.
Page, Seth
Austin, Colleen
Deming, Richard L.
Ferreira, Margaret A.
Lafky, Jacqueline M.
Birrell, Stephen N.
Loprinzi, Charles L.
-
Funding
Funding for this research was provided by:
National Cancer Institute (UG1CA189823, UG1CA232760, U24CA196171, UG1CA189858, UG1CA189997, U10CA180820, UG1CA189861, U10CA180868)
- License Information
-
More Information
Article History
Received: 19 November 2019
Accepted: 14 April 2020
First Online: 6 May 2020
Compliance with ethical standards
:
: The US NCI provided funding for this trial.The authors have no financial relationship with any private company regarding this research with the exception that Dr. Birrell reports personal fees from Havah Therapeutics, that is developing androgen-based therapies for women, and has a patent AU2005905768A0; additionally, Dr. Glaser has a patent (US 10,071,104 B2) related to this topic.
: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
